Literature DB >> 9598449

Prevalence of and risk factors for anemia in young children in southern Cameroon.

M Cornet1, J Y Le Hesran, N Fievet, M Cot, P Personne, R Gounoue, M Beyeme, P Deloron.   

Abstract

Anemia during childhood remains a major public health challenge in sub-Saharan Africa. To determine the prevalence of and the main risk factors for anemia in young children, we conducted a longitudinal survey in Ebolowa in southern Cameroon. Children were enrolled in two cohorts and followed during a three-year period: the first cohort was composed of 122 children from 0 to 36 months of age and the second cohort was composed of 84 children from 24 to 60 months of age. The two cohorts were followed weekly for symptomatic malaria, monthly for both symptomatic and asymptomatic malaria, and every six months for hematologic data; the children were grouped into six-month age groups. The prevalence of anemia (hemoglobin [Hb] level < 11 g/dl) was the highest in the six-month-old age group (47%) and the age-related evolution clearly showed a decrease in the prevalence from three years of age. Thus, 42% of the children less than three years of age were anemic, while 21% of the children between three and five years of age were anemic. The lowest mean +/- SD Hb content (10.7 +/- 2.1 g/dl) was observed in the six-month-old children and a regular improvement in the Hb level occurred from six months to three years of age. A stabilization was observed at a level of approximately 12 g/dl. At any age, there was no difference in mean Hb levels between children with AS and AA Hb genotypes. Hookworm infection was diagnosed in two children in the study population. Results of a multivariate analysis showed that placental malaria infection was the strongest risk factor for anemia in the six-month-old children (odds ratio [OR] = 3.6; 95% confidence interval [CI] = 1.1-12.3) and was independent of the frequency of parasitemia, parasitemia at the time of Hb measurement, or microcytosis. In the one-year-old age group, microcytosis was a significant factor related to anemia (OR = 2.8, 95% CI = 1-7.8) pointing out the role of iron deficiency at this age. Parasitemia at the time of Hb measurement was significantly associated with anemia in all age groups (except in 54- and 60-month-old groups). Strategies to decrease the prevalence of anemia in young children in southern Cameroon should include chemoprophylaxis for pregnant women, prevention of acquired malaria infection in both pregnancy and infancy, and prevention of nutritional iron deficiency.

Entities:  

Mesh:

Year:  1998        PMID: 9598449     DOI: 10.4269/ajtmh.1998.58.606

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  33 in total

1.  Placental malaria-associated suppression of parasite-specific immune response in neonates has no major impact on systemic CD4 T cell homeostasis.

Authors:  Valérie Soulard; Martin Amadoudji Zin; Catherine Fitting; Samad Ibitokou; Mayke Oesterholt; Adrian J F Luty; René-Xavier Perrin; Achille Massougbodji; Philippe Deloron; Antonio Bandeira; Nadine Fievet
Journal:  Infect Immun       Date:  2011-04-25       Impact factor: 3.441

2.  Prevalence and Factors Associated with Anemia Among Children Under 5 Years of Age--Uganda, 2009.

Authors:  Manoj P Menon; Steven S Yoon
Journal:  Am J Trop Med Hyg       Date:  2015-06-08       Impact factor: 2.345

3.  A comparison of iron and folate with folate alone in hematologic recovery of children treated for acute malaria.

Authors:  Samuel N Gara; Aboi J K Madaki; Tom D Thacher
Journal:  Am J Trop Med Hyg       Date:  2010-10       Impact factor: 2.345

4.  Changes in haemoglobin levels in infants in Malawi: effect of low birth weight and fetal anaemia.

Authors:  S le Cessie; F H Verhoeff; G Mengistie; P Kazembe; R Broadhead; B J Brabin
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-05       Impact factor: 5.747

5.  Iron Supplementation in Iron-Replete and Nonanemic Pregnant Women in Tanzania: A Randomized Clinical Trial.

Authors:  Analee J Etheredge; Zul Premji; Nilupa S Gunaratna; Ajibola Ibraheem Abioye; Said Aboud; Christopher Duggan; Robert Mongi; Laura Meloney; Donna Spiegelman; Drucilla Roberts; Davidson H Hamer; Wafaie W Fawzi
Journal:  JAMA Pediatr       Date:  2015-10       Impact factor: 16.193

6.  Predictors and consequences of anaemia among antiretroviral-naïve HIV-infected and HIV-uninfected children in Tanzania.

Authors:  Anirban Chatterjee; Ronald J Bosch; Roland Kupka; David J Hunter; Gernard I Msamanga; Wafaie W Fawzi
Journal:  Public Health Nutr       Date:  2009-08-04       Impact factor: 4.022

7.  [Frequency of severe anemia in children aged 2 months to 15 years at Mother and Child Centre of the Chantal Biya Foundation Yaounde, Cameroon].

Authors:  Félicitée Nguefack; David Chelo; Mathurin Cyrille Tejiokem; Angèle Pondy; Mina Julie Njiki kinkela; Roger Dongmo; Hubert Désiré Mbassi Awa; Jean Taguebue; Georgette Guemkam; Clémence Vougmo Meguejio Njua; Paul Olivier Koki Ndombo
Journal:  Pan Afr Med J       Date:  2012-06-23

8.  Can prenatal malaria exposure produce an immune tolerant phenotype? A prospective birth cohort study in Kenya.

Authors:  Indu Malhotra; Arlene Dent; Peter Mungai; Alex Wamachi; John H Ouma; David L Narum; Eric Muchiri; Daniel J Tisch; Christopher L King
Journal:  PLoS Med       Date:  2009-07-28       Impact factor: 11.069

9.  Impact of Plasmodium falciparum infection on the frequency of moderate to severe anaemia in children below 10 years of age in Gabon.

Authors:  Marielle K Bouyou-Akotet; Arnaud Dzeing-Ella; Eric Kendjo; Diane Etoughe; Edgard B Ngoungou; Timothy Planche; Jean Koko; Maryvonne Kombila
Journal:  Malar J       Date:  2009-07-20       Impact factor: 2.979

10.  A longitudinal study on anaemia in children with Plasmodium falciparum infection in the Mount Cameroon region: prevalence, risk factors and perceptions by caregivers.

Authors:  Irene Ule Ngole Sumbele; Moses Samje; Theresa Nkuo-Akenji
Journal:  BMC Infect Dis       Date:  2013-03-05       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.